A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

Exclusion criteria

• ✕. Patients with active cancer; vascular malformation, abscess, or other major non-ischemic brain disease (e.g., multiple sclerosis).
• ✕. With a modified Rankin Score (mRS) of 3 or higher before onset.
• ✕. Underwent intravenous thrombolytic therapy (intravenous rtPA) or mechanical thrombectomy within 24 hours of the screening visit.
• ✕. History of hypersensitivity to IP or components
• ✕. Not suitable for aspirin administration at the discretion of the investigator